Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria
Open Access
- 13 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology Plus
- Vol. 3 (1) , 100139
Abstract
No abstract availableKeywords
Funding Information
- University of Washington
- Centers for Disease Control and Prevention
- U.S. President’s Emergency Plan for AIDS Relief
- Bill and Melinda Gates Foundation
- Centers for Disease Control and Prevention Foundation
- Global Fund to Fight AIDS, Tuberculosis and Malaria
- Bundesministerium für Gesundheit
- World Health Organization
- British Columbia Centre for Disease Control
- University of Maryland, Baltimore County
This publication has 35 references indexed in Scilit:
- Technical considerations to development of serological tests for SARS-CoV-2Talanta, 2021
- Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, BeninEmerging Infectious Diseases, 2021
- High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan AfricaInternational Journal of Infectious Diseases, 2021
- Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from IndonesiaInternational Journal of Infectious Diseases, 2021
- Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 ProteinsTransplantation, 2020
- Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, ColombiaInternational Journal of Infectious Diseases, 2020
- Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive resultsJournal of Clinical Pathology, 2020
- Evaluation of SARS-CoV-2 serology assays reveals a range of test performanceNature Biotechnology, 2020
- Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue VirusesClinical Infectious Diseases, 2020
- Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on SpecificityClinical Chemistry, 2020